Ubiquitous Pharmacogenomics (U-PGx)
  • Home
  • U-PGx
    • U-PGx Consortium
    • Work Packages
    • Deliverables
    • U-PGx Publications
    • Ethics
    • Scientific Advisory Board
  • PREPARE
    • Study Overview
    • Pharmacogenomics guidelines (DPWG)
    • FAQ
    • Downloads & Web Resources
    • LIM Survey
    • Data Collection
    • Ethics
  • Education
    • Education material
    • Events Calendar
    • Upcoming U-PGx Events
    • Past U-PGx Events
    • Links
    • Other PGx Organizations
      • PGRN
  • News
  • Login Members
  • Contact

Publications

Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation. Cecchin E, De Mattia E, Ecca F, Toffoli G. Drug Resist Updat. 2018 Jul;39:18-40.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

From hype to reality: data science enabling personalized medicine. Fröhlich H, et al. BMC Med. 2018 Aug 27;16(1):150.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

Personalized laboratory medicine: a patient-centered future approach. Prodan Žitnik I, et al.; behalf of EFLM/ESPT working group of Personalised Laboratory Medicine on. Clin Chem Lab Med. 2018 Nov 27;56(12):1981-1991.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

Drinking Ethanol Has Few Acute Effects on CYP2C9, CYP2C19, NAT2, and P-Glycoprotein Activities but Somewhat Inhibits CYP1A2, CYP2D6, and Intestinal CYP3A: So What? Gazzaz M, et al. Clin Pharmacol Ther. 2018 Dec;104(6):1249-1259.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

Improving decision making on DPYD and UGT1A1*28 patients’ profiling with an innovative reimbursement strategy. Roncato R, Cecchin E, Toffoli G. Pharmacogenomics. 2018 Mar;19(4):301-304.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

How to Consider Rare Genetic Variants in Personalized Drug Therapy. Lauschke VM, Ingelman-Sundberg M. Clin Pharmacol Ther. 2018 May;103(5):745-748.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

CPIC Guideline for CYP2D6 and Tamoxifen Therapy. Goetz MP, Sangkuhl K, Guchelaar HJ, Schwab M, Province M, Whirl-Carrillo M, Symmans WF, McLeod HL, Ratain MJ, Zembutsu H, Gaedigk A, van Schaik RH, Ingle JN, Caudle KE, Klein TE. Clin Pharmacol Ther. 2018 May;103(5):770-777.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC). Bergmeijer TO, et al.; ICPC Investigators. Am Heart J. 2018 Apr;198:152-159.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia. Fujiwara R, Haag M, Schaeffeler E, Nies AT, Zanger UM, Schwab M. Hepatology. 2018 Apr;67(4):1609-1619.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

Implementing pharmacogenomics decision support across seven European countries: The U-PGx project. Blagec K, Koopmann R, Crommentuijn-van Rhenen M, Holsappel I, van der Wouden CH, Konta L, Xu H, Steinberger D, Just E, Swen JJ, Guchelaar HJ, Samwald M. J Am Med Inform Assoc. 2018 Jul 1;25(7):893-898.

Posted on May 15, 2019 by Wendy van Hemmen

Continue reading →

Posted in Publications

Posts navigation

← Older posts
Newer posts →

Recent Posts

  • Dr. Cristina Lucía Dávila Fajardo obtains PhD degree in pharmacogenetics
  • Cathelijne van der Wouden obtains PhD degree in pharmacogenetics
  • 2,500 patients enrolled in the PREPARE study since cross-over!
  • The 3rd U-PGx Personalized Medicine Public Day was successfully organized in Patras, Greece
  • Educating the Next Generation of Pharmacogenomics Experts
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668353.